COGT Cogent Biosciences Inc reports wider Q4 2025 loss than consensus analyst estimates with shares dipping 036 percent in todays trading Oxford OXSQ Stock Undervalued vs Peers Institutional Selling 20260416 Rithm Capital RITM Stock Breakout Level Momentum Building 20260418 The long term thesis for Roivant ROIV in plain sight 099 20260508 MCFT Q1 2026 Earnings MasterCraft Beats EPS Estimates on Strong Operational Execution Afghanistans Economic Collapse Drives Desperate Acts Fathers Selling Children to Survive Liberty LILA Q1 2026 Underperforms Key Challenges Ahead Cathie Wood Adjusts ARK Invests Defense Holdings Amid Focus on Contracts and International Sales PPC Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction RMR Q1 2026 Earnings EPS Misses Estimates but Stock Steadies IEP Q1 2026 Earnings Massive EPS Miss Amid Operational Challenges VRDN Q1 2026 Earnings NarrowerthanExpected Loss as Viridian Advances Clinical Pipeline Silo Pharma Inc SILO Q4 2023 Earnings Widening Losses as PreRevenue Biotech Focuses on Pipeline Progress Investors Title Company Q4 2025 Earnings EPS of 397 Reported Stock Edges Lower